![Logo for Belite Bio Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fb051d-2024-05-02-02-01-25.png&w=256&q=100)
Belite Bio Investor Relations Material
Latest events
![Logo for Belite Bio Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fb051d-2024-05-02-02-01-25.png&w=128&q=100)
Q2 2024
Belite Bio
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Belite Bio Inc
Access all reports
Belite Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing novel therapeutics targeting retinal degenerative eye diseases and certain metabolic diseases. The company's primary focus includes conditions such as atrophic age-related macular degeneration (AMD) and autosomal recessive Stargardt disease type 1 (STGD1), which can lead to permanent blindness. Additionally, Belite Bio is exploring treatments for metabolic disorders like non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout. Belite Bio, Inc. was founded in 2016 and is headquartered in San Diego, California. The company's shares are listed on the NASDAQ.
Key slides for Belite Bio Inc
![Tinlarebant ( LBS -](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fbelite-bio-inc-q2-2024-3ee7d39aa619e5bd%2F8.png&w=3840&q=75)
![Logo for Belite Bio Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fb051d-2024-05-02-02-01-25.png&w=128&q=100)
Q2 2024
Belite Bio Inc
![Tinlarebant ( LBS -](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fbelite-bio-inc-q2-2024-3ee7d39aa619e5bd%2F11.png&w=3840&q=75)
![Logo for Belite Bio Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fb051d-2024-05-02-02-01-25.png&w=128&q=100)
Q2 2024
Belite Bio Inc
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2Fbbbaafadba%2Fpontis-dackmo_strong-opinions-loosely-held.png&w=3840&q=75)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F7455f6afd1%2Fnovo-nordisk_the-danish-pharmaceutical-titan.png&w=3840&q=75)
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F5533bee49f%2Fthe-toyota-way.png&w=3840&q=75)
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
BLTE
Country
🇺🇸 United States